How Many Dexamethasone Doses Should Be Given Perioperatively?
Launched by MAYO CLINIC · Nov 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different doses of a medication called dexamethasone can help patients during and after total knee replacement surgery (also known as total knee arthroplasty). The goal is to find out which dose is the most effective and safest for reducing pain, nausea, and the need for additional pain medication after the surgery, while also minimizing any complications that might arise.
To participate in this study, you need to be over 18 years old and scheduled for a primary total knee replacement surgery. Unfortunately, if you have certain conditions like recent corticosteroid use, inflammatory arthritis, or kidney and liver problems, you wouldn't be eligible to join. If you do participate, you can expect to receive a specific dose of dexamethasone around the time of your surgery, and your doctors will monitor your recovery closely to gather important information about how well the medication works. This study is currently recruiting participants, and it's open to anyone who meets the criteria, regardless of gender.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Age \> 18 years
- • Primary total knee arthroplasty
- • Exclusion Criteria
- • Age \< 18 year
- • Revision or unicompartmental knee arthroplasty
- • Corticosteroid use within 3 months prior to TKA
- • Inflammatory arthritis
- • Current systemic fungal infection
- • Renal or liver failure
- • Prior adverse reaction to corticosteroid
- • Primary TKA requiring hardware removal
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Charles Hannon
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported